SİSPLATİN İLE İNDUKLENEN PREMATÜR OVER YETMEZLİĞİ SIÇAN MODELİNDE DİOSMİN UYGULAMASININ ETKİLERİ

Yıl 2022, , 912 - 916, 30.11.2022

Ali Gürsoy , Ayşe Gökçen Sade

https://doi.org/10.16899/jcm.1166435

Cited By: 2

Öz

Amaç
Sisplatin kaynaklı erken yumurtalık yetmezliği (POF) modelinde diosmin uygulamasının biyokimyasal ve histopatolojik potansiyel yararlı etkilerini incelemeyi amaçladık.

Gereç ve Yöntem
Yirmi sekiz sıçan dört gruba ayrıldı. A Grubu sıçanlar (n:7) plasebo grubu olarak belirlendi. Kalan yirmi bir sıçana, POF modeli oluşturmak için 10 gün boyunca 1.5 mg/kg/gün sisplatin intraperitoneal olarak uygulandı. Daha sonra rastgele 3 alt gruba ayrıldılar.
Grup B, sisplatine bağlı yumurtalık yetmezliği grubu olarak belirlendi. POF modeli oluşturulurken C grubu sıçanlara aynı anda 10 gün süreyle 100mg/kg/gün diosmin verildi. D grubuna ise POF modeli oluşturulduktan sonra 10 gün süreyle 100mg/kg/gün diosmin verildi.
Yirminci günün sonunda AMH, FSH, SOD ve Estradiol değerlerinin incelenmesi için kan örnekleri alındı. Ayrıca histopatolojik inceleme için sol overler rezeke edildi.

Bulgular
Sisplatin ile indüklenen grupta, diğer gruplara kıyasla daha düşük SOD, AMH ve E2 seviyeleri izlendi (p<0.05). SOD, AMH ve E2 değerleri sham grubu, grup C ve grup D arasında anlamlı farklılık göstermedi (p>0.05). Grup C, grup D ve sham grupları arasında FSH değerlerinde anlamlı (p>0.05) fark gözlenmedi.
Grup C ve D arasında sham grubuna göre sekonder folikül ve antral folikül sayısında anlamlı (p>0.05) fark saptanmadı. Primordial folikül sayısı grup C'de grup B'ye göre anlamlı derecede yüksekti (p<0.05). Primer folikül ve toplam folikül sayısı grup D’de grup B'ye göre anlamlı (p<0.05) daha yüksekti.

Sonuç
Diosmin tedavisi serum östrojen, AMH ve SOD düzeylerini artırırken FSH düzeylerini düşürdü. Ayrıca foliküller üzerinde önemli bir koruyucu etki göstermiştir. Kemoterapi sonrası veya kemoterapi ile kombinasyon halinde diosmin uygulanması, yumurtalık rezervinin ve foliküllerin yapısının korunmasında yardımcı etkinlik sağlamaktadır.

Anahtar Kelimeler

Antimüllerian Hormon, Diosmin, Overyan Folikül, Primer Yumurtalık Yetmezliği

Destekleyen Kurum

Yok

Proje Numarası

Yok

EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL

Öz

m
We aimed to examine the potential beneficial effects of diosmin administration on cisplatin - induced premature ovarian failure (POF) in a rat model

Material and Methods
Twenty-eight rats were divided into four groups. Group A rats (n:7) were determined as the sham group. The remaining rats received an intraperitoneal injection of 1.5 mg/kg/day cisplatin for 10 days to create a POF model. Then, they were randomly divided into 3 subgroups.
Group B was determined as POF group. Group C rats were given 100mg/kg/day diosmin for 10 days simultaneously while creating POF model. Group D rats were given 100mg/kg/day diosmin for 10 days after POF model was created. Twentieth day blood samples were taken and left ovaries were resected for examination.

Results
CIS-induced rats showed reduced levels of SOD, AMH and E2 compared to sham group rats (p<0.05). SOD, AMH and E2 values were not significantly different (p>0.05) between the sham group, group C and D. No significant (p>0.05) difference in FSH value was observed between group C, D and sham groups.
There was no significant (p>0.05) difference in the number of secondary and antral follicles between group C and D compared to the sham group. Primordial follicle count was significantly higher in group C than group B (p<0.05). Primary and total follicle count in group D was significantly (p<0.05) higher than group B.

Conclusion
Diosmin administration after chemotherapy or in combination with chemotherapy has shown helpful efficacy in maintaining the ovarian reserve and the structure of the follicles.

Anahtar Kelimeler

Anti-Mullerian Hormone, Diosmin, Ovarian Follicle, Primary Ovarian Insufficiency

Proje Numarası

Yok

Kaynakça

• Referans1. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;1:9. Published 2006 Apr 6. doi:10.1186/1750-1172-1-9
• Referans2. Mauri D, Gazouli I, Zarkavelis G, et al. Chemotherapy Associated Ovarian Failure. Front Endocrinol (Lausanne). 2020;11:572388. Published 2020 Dec 8. doi:10.3389/fendo.2020.572388
• Referans3. Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf. 2005;28(5):401-416. doi:10.2165/00002018-200528050-00004
• Referans4. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604-606.
• Referans5. Blumenfeld Z, Evron A. Endocrine prevention of chemotherapy-induced ovarian failure. Curr Opin Obstet Gynecol. 2016;28(4):223-229. doi:10.1097/GCO.0000000000000278
• Referans6. Woad KJ, Watkins WJ, Prendergast D, Shelling AN. The genetic basis of premature ovarian failure. Aust N Z J Obstet Gynaecol. 2006;46(3):242-244. doi:10.1111/j.1479-828X.2006.00585.x
• Referans7. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14(5):1718-1729. doi:10.1200/JCO.1996.14.5.1718
• Referans8. Huwait E, Mobashir M. Potential and Therapeutic Roles of Diosmin in Human Diseases. Biomedicines. 2022;10(5):1076. Published 2022 May 6. doi:10.3390/biomedicines10051076
• Referans9. Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Pharmacology of Diosmin, a Citrus Flavone Glycoside: An Updated Review. Eur J Drug Metab Pharmacokinet. 2022;47(1):1-18. doi:10.1007/s13318-021-00731-y
• Referans10. Jin H, Yamamoto N, Uchida K, Terai S, Sakaida I. Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet. Biochem Biophys Res Commun. 2007;364(4):801-807. doi:10.1016/j.bbrc.2007.10.083
• Referans11. Yuemaier M, Tuerhong M, Keremu A, et al. Research on Establishment of Abnormal Phlegmatic Syndrome with Premature Ovarian Failure Rat Model and Effects of Balgham Munziq Treatment. Evid Based Complement Alternat Med. 2018;2018:3858209. Published 2018 Mar 26. doi:10.1155/2018/3858209
• Referans12. Mirshekar MA, Fanaei H, Keikhaei F, Javan FS. Diosmin improved cognitive deficit and amplified brain electrical activity in the rat model of traumatic brain injury. Biomed Pharmacother. 2017;93:1220-1229. doi:10.1016/j.biopha.2017.07.014
• Referans13. Kilicoglu SS, Tanrikulu Y, Kismet K, et al. The effect of diosmin on pancreatic injury induced by hepatic ischemia reperfusion in rats. Bratisl Lek Listy. 2013;114(3):119-124. doi:10.4149/bll_2013_026
• Referans14. Ozler A, Turgut A, Soydinç HE, et al. The biochemical and histologic effects of adnexal torsion and early surgical intervention to unwind detorsion on ovarian reserve: an experimental study. Reprod Sci. 2013;20(11):1349-1355. doi:10.1177/1933719113485300
• Referans15. Female reproductive system. Young B, Heath WJ, editors. Wheater’s Functional Histology: a text and colour atlas. fourth ed., Sydney: Churchill Livingstone; 2000.
• Referans16. Gui H, Jin Y, Lin A, Wang P, Wang Y, Zhu H. Rosmarinic acid relieves cisplatin-induced ovary toxicity in female mice via suppression of oxidative stress and inflammation. J Biochem Mol Toxicol. 2021;35(9):e22839. doi:10.1002/jbt.22839
• Referans17. Zhang Z, Liu Q, Yang J, et al. The proteomic profiling of multiple tissue damage in chickens for a selenium deficiency biomarker discovery. Food Funct. 2020;11(2):1312-1321. doi:10.1039/c9fo02861g
• Referans18. Yasui K, Baba A. Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflamm Res. 2006;55(9):359-363. doi:10.1007/s00011-006-5195-y
• Referans19. Eraslan G, Sarıca ZS, Bayram LÇ, Tekeli MY, Kanbur M, Karabacak M. The effects of diosmin on aflatoxin-induced liver and kidney damage. Environ Sci Pollut Res Int. 2017;24(36):27931-27941. doi:10.1007/s11356-017-0232-7
• Referans20. Ali N, AlAsmari AF, Imam F, et al. Protective effect of diosmin against doxorubicin-induced nephrotoxicity. Saudi J Biol Sci. 2021;28(8):4375-4383. doi:10.1016/j.sjbs.2021.04.030
• Referans21. Srinivasan S, Pari L. Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Chem Biol Interact. 2012;195(1):43-51. doi:10.1016/j.cbi.2011.10.003
• Referans22. Ahmed S, Mundhe N, Borgohain M, et al. Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy. Inflammation. 2016;39(5):1783-1797. doi:10.1007/s10753-016-0413-4
• Referans23. Bedoschi G, Navarro PA, Oktay K. Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncol. 2016;12(20):2333-2344. doi:10.2217/fon-2016-0176
• Referans24. Moolhuijsen LME, Visser JA. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020;105(11):3361-3373. doi:10.1210/clinem/dgaa513
• Referans25. Findlay JK, Hutt KJ, Hickey M, Anderson RA. How Is the Number of Primordial Follicles in the Ovarian Reserve Established?. Biol Reprod. 2015;93(5):111. doi:10.1095/biolreprod.115.133652
• Referans26. Calis P, Bozdag G, Karakoc Sokmensuer L, Kender N. Does ischemia-reperfusion injury affect ovarian reserve and follicle viability in a rat model with adnexal torsion?. Eur J Obstet Gynecol Reprod Biol. 2015;185:126-130. doi:10.1016/j.ejogrb.2014.12.006